$OPTN
OptiNose, Inc. Stock $optn

$optn Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-K Financial Statement

#000149465019000020 Filed on March 06, 2019

Income Statement

Concept	2019 Q1	2018 Q4	2018
Revenue	$4.476M	$3.020M	$7.065M
YoY Change	417.46%
Cost Of Revenue	$738.0K	$720.0K	$1.588M
YoY Change	269.0%
Gross Profit	$3.738M	$2.310M	$5.477M
YoY Change	462.11%
Gross Profit Margin	83.51%	76.49%	77.52%
Selling, General & Admin	$26.34M	$23.66M	$95.62M
YoY Change	-5.97%	28.0%	201.65%
% of Gross Profit	704.65%	1024.24%	1745.81%
Research & Development	$4.562M	$3.360M	$10.10M
YoY Change	168.2%	177.23%	-40.0%
% of Gross Profit	122.04%	145.45%	184.39%
Depreciation & Amortization	$269.0K	$210.0K	$539.0K
YoY Change	71.34%	200.0%	224.7%
% of Gross Profit	7.2%	9.09%	9.84%
Operating Expenses	$31.64M	$27.02M	$105.7M
YoY Change	5.78%	37.19%	117.84%
Operating Profit	-$27.16M	-$24.71M	-$100.2M
YoY Change	-6.48%	25.46%	106.55%
Interest Expense	$2.388M	-$1.690M	$9.229M
YoY Change	8.89%	-1636.36%	914.18%
% of Operating Profit
Other Income/Expense, Net	$0.00	$30.00K	$410.0K
YoY Change	-100.0%	-25.0%	156.25%
Pretax Income	-$28.87M	-$26.38M	-$146.2M
YoY Change	-5.56%	34.94%	380.08%
Income Tax
% Of Pretax Income
Net Earnings	-$28.87M	-$26.38M	-$106.7M
YoY Change	-5.55%	34.93%	118.11%
Net Earnings / Revenue	-645.08%	-873.51%	-1509.67%
Basic Earnings Per Share			-$2.68
Diluted Earnings Per Share	-$699.7K	-$639.1K	-$2.68
COMMON SHARES
Basic Shares Outstanding	41.26M shares	41.23M shares	39.77M shares
Diluted Shares Outstanding			39.77M shares

Balance Sheet

Concept	2019 Q1	2018 Q4	2018
SHORT-TERM ASSETS
Cash & Short-Term Investments	$171.3M	$201.0M	$201.0M
YoY Change	-18.35%	-14.43%	-14.43%
Cash & Equivalents	$171.3M	$201.0M	$201.0M
Short-Term Investments
Other Short-Term Assets	$3.800M	$2.183M	$2.200M
YoY Change	171.43%	74.08%	69.23%
Inventory	$5.716M	$7.132M	$7.100M
Prepaid Expenses
Receivables	$5.793M	$2.310M	$2.600M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$186.8M	$212.9M	$212.9M
YoY Change	-13.95%	-10.63%	-10.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.715M	$3.884M	$3.900M
YoY Change	19.76%	51.48%	50.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.495M	$248.0K	$200.0K
YoY Change	538.11%	-38.77%	-50.0%
Total Long-Term Assets	$6.210M	$4.132M	$4.100M
YoY Change	77.78%	39.17%	41.38%
TOTAL ASSETS
Total Short-Term Assets	$186.8M	$212.9M	$212.9M
Total Long-Term Assets	$6.210M	$4.132M	$4.100M
Total Assets	$193.0M	$217.0M	$217.0M
YoY Change	-12.5%	-10.01%	-10.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.676M	$7.116M	$7.100M
YoY Change	-4.0%	20.75%	20.34%
Accrued Expenses	$17.68M	$18.42M	$18.40M
YoY Change	22.01%	111.78%	111.49%
Deferred Revenue	$0.00	$160.0K
YoY Change		-13.98%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$26.87M	$25.70M	$25.70M
YoY Change	19.48%	73.9%	73.65%
LONG-TERM LIABILITIES
Long-Term Debt	$72.70M	$72.50M	$72.50M
YoY Change	0.97%	0.89%	0.83%
Other Long-Term Liabilities	$1.100M	$200.0K	$200.0K
YoY Change
Total Long-Term Liabilities	$73.80M	$72.50M	$72.70M
YoY Change	2.5%	0.89%	1.11%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.87M	$25.70M	$25.70M
Total Long-Term Liabilities	$73.80M	$72.50M	$72.70M
Total Liabilities	$100.6M	$98.38M	$98.40M
YoY Change	6.55%	13.55%	13.63%
SHAREHOLDERS EQUITY
Retained Earnings	-$346.8M	-$317.9M
YoY Change	43.4%	50.48%
Common Stock	$439.2M	$436.6M
YoY Change	19.33%	19.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$92.35M	$118.6M	$118.6M
YoY Change
Total Liabilities & Shareholders Equity	$193.0M	$217.0M	$217.0M
YoY Change	-12.5%	-10.01%	-10.0%

Cashflow Statement

Concept	2019 Q1	2018 Q4	2018
OPERATING ACTIVITIES
Net Income	-$28.87M	-$26.38M	-$106.7M
YoY Change	-5.55%	34.93%	118.11%
Depreciation, Depletion And Amortization	$269.0K	$210.0K	$539.0K
YoY Change	71.34%	200.0%	224.7%
Cash From Operating Activities	-$29.69M	-$20.20M	-$91.82M
YoY Change	29.12%	46.27%	157.33%
INVESTING ACTIVITIES
Capital Expenditures	$168.0K	-$240.0K	$1.690M
YoY Change	-56.02%	-80.0%	-29.76%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$168.0K	-$240.0K	-$1.690M
YoY Change	-56.02%	-80.0%	-29.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00		$0.00
YoY Change			-100.0%
Debt Paid & Issued, Net			$0.00
YoY Change
Cash From Financing Activities	$188.0K	-80.00K	$59.58M
YoY Change	-111.1%	-100.04%	-74.77%
NET CHANGE
Cash From Operating Activities	-$29.69M	-20.20M	-$91.82M
Cash From Investing Activities	-$168.0K	-240.0K	-$1.690M
Cash From Financing Activities	$188.0K	-80.00K	$59.58M
Net Change In Cash	-$29.68M	-20.52M	-$33.86M
YoY Change	18.37%	-111.07%	-117.1%
FREE CASH FLOW
Cash From Operating Activities	-$29.69M	-$20.20M	-$91.82M
Capital Expenditures	$168.0K	-$240.0K	$1.690M
Free Cash Flow	-$29.86M	-$19.96M	-$93.51M
YoY Change	27.72%	58.29%	145.52%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018	dei	Amendment Flag AmendmentFlag	false
CY2018	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2018	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018	dei	Document Period End Date DocumentPeriodEndDate	2018-12-31
CY2018	dei	Document Type DocumentType	10-K
CY2018	dei	Entity Central Index Key EntityCentralIndexKey	0001494650
CY2019Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	41264422	shares
CY2018	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2018	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2018	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2018	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2018Q2	dei	Entity Public Float EntityPublicFloat	682400000	USD
CY2018	dei	Entity Registrant Name EntityRegistrantName	OptiNose, Inc.
CY2018	dei	Entity Shell Company EntityShellCompany	false
CY2018	dei	Entity Small Business EntitySmallBusiness	true
CY2018	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2018	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2017Q4	optn	Accrued Product Allowances Current AccruedProductAllowancesCurrent	0	USD
CY2018Q4	optn	Accrued Product Allowances Current AccruedProductAllowancesCurrent	2856000	USD
CY2017Q4	optn	Accrued Researchand Development Current AccruedResearchandDevelopmentCurrent	80000	USD
CY2018Q4	optn	Accrued Researchand Development Current AccruedResearchandDevelopmentCurrent	933000	USD
CY2017Q4	optn	Accrued Sales Organization Expenses Current AccruedSalesOrganizationExpensesCurrent	1432000	USD
CY2018Q4	optn	Accrued Sales Organization Expenses Current AccruedSalesOrganizationExpensesCurrent	4482000	USD
CY2017Q4	optn	Accrued Selling Generaland Administrative Current AccruedSellingGeneralandAdministrativeCurrent	2031000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	392000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3171000	USD
CY2018Q4	optn	Accrued Selling Generaland Administrative Current AccruedSellingGeneralandAdministrativeCurrent	4812000	USD
CY2017	optn	Debt Discount Amortization Period DebtDiscountAmortizationPeriod	P5Y6M
CY2017	optn	Deferred Offering Costs W Ithin Accounts Payableand Accrued Expenses DeferredOfferingCostsWIthinAccountsPayableandAccruedExpenses	0	USD
CY2018	optn	Deferred Offering Costs W Ithin Accounts Payableand Accrued Expenses DeferredOfferingCostsWIthinAccountsPayableandAccruedExpenses	146000	USD
CY2017Q4	optn	Deferred Tax Assets Interest Expense DeferredTaxAssetsInterestExpense	783000	USD
CY2018Q4	optn	Deferred Tax Assets Interest Expense DeferredTaxAssetsInterestExpense	1267000	USD
CY2017Q4	optn	Deferred Tax Assets Prepaid License Arrangement DeferredTaxAssetsPrepaidLicenseArrangement	0	USD
CY2018Q4	optn	Deferred Tax Assets Prepaid License Arrangement DeferredTaxAssetsPrepaidLicenseArrangement	11562000	USD
CY2017	optn	Effective Income Tax Rate Reconciliation Foreign Exchange Other Percent EffectiveIncomeTaxRateReconciliationForeignExchangeOtherPercent	-0.006
CY2018	optn	Effective Income Tax Rate Reconciliation Foreign Exchange Other Percent EffectiveIncomeTaxRateReconciliationForeignExchangeOtherPercent	0.000
CY2017	optn	Effective Income Tax Rate Reconciliation Foreign Operations Impact Percent EffectiveIncomeTaxRateReconciliationForeignOperationsImpactPercent	0.000
CY2018	optn	Effective Income Tax Rate Reconciliation Foreign Operations Impact Percent EffectiveIncomeTaxRateReconciliationForeignOperationsImpactPercent	-0.072
CY2018Q4	optn	Future Rent Expense FutureRentExpense	2750000	USD
CY2017	optn	Grantand Other Income GrantandOtherIncome	162000	USD
CY2018	optn	Grantand Other Income GrantandOtherIncome	406000	USD
CY2017	optn	Increase Decrease In Grantsand Other Receivables IncreaseDecreaseInGrantsandOtherReceivables	-337000	USD
CY2018	optn	Increase Decrease In Grantsand Other Receivables IncreaseDecreaseInGrantsandOtherReceivables	196000	USD
CY2017	optn	Increase Decreasein Depositsand Other Assets IncreaseDecreaseinDepositsandOtherAssets	-2358000	USD
CY2018	optn	Increase Decreasein Depositsand Other Assets IncreaseDecreaseinDepositsandOtherAssets	762000	USD
CY2017	optn	Interest Expense Debt Back End Fees InterestExpenseDebtBackEndFees	2000000	USD
CY2018	optn	Number Of Operating Leases NumberOfOperatingLeases	4	lease
CY2017	optn	Proceedsfrom Issuanceof Common Stock Under Employee Stock Purchase Plan ProceedsfromIssuanceofCommonStockUnderEmployeeStockPurchasePlan	0	USD
CY2018	optn	Proceedsfrom Issuanceof Common Stock Under Employee Stock Purchase Plan ProceedsfromIssuanceofCommonStockUnderEmployeeStockPurchasePlan	739000	USD
CY2018Q4	optn	Vote Per Share VotePerShare	1	vote
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	5893000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7116000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2310000	USD
CY2017Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	4163000	USD
CY2018Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	3635000	USD
CY2017Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	448000	USD
CY2018Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	564000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8698000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	18421000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	355000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1151000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-111000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-57000	USD
CY2017Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	365838000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	436554000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5096000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8645000	USD
CY2017	us-gaap	Advertising Expense AdvertisingExpense	1833000	USD
CY2018	us-gaap	Advertising Expense AdvertisingExpense	9767000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5096000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8543000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	35632000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	53029000	USD
CY2017	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	198000	USD
CY2018	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	404000	USD
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4031856	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8081596	shares
CY2018Q4	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	20050	sqft
CY2018Q1	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	30000	sqft
CY2017Q4	us-gaap	Assets Assets	241136000	USD
CY2018Q4	us-gaap	Assets Assets	216989000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	238167000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	212857000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36847000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	234875000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	201011000	USD
CY2017	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	198028000	USD
CY2018	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-33864000	USD
CY2017Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	234854000	USD
CY2018Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	200990000	USD
CY2017Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	233772000	USD
CY2018Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	199507000	USD
CY2018Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	8.16
CY2018Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1866831	shares
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41227530	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41227530	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37802556	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37802556	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	38000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	41000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-48914000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-106604000	USD
CY2017Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	186000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	160000	USD
CY2017	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	237259000	USD
CY2018	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	USD
CY2017Q4	us-gaap	Convertible Debt ConvertibleDebt	0	USD
CY2018Q4	us-gaap	Convertible Debt ConvertibleDebt	0	USD
CY2017	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	0	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1588000	USD
CY2017Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	2181000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	0	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	409000	USD
CY2017Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	2485000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	29636000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	32548000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	1674000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	1701000	USD
CY2018Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	2485000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	55000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense DeferredTaxAssetsTaxDeferredExpense	972000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	3493000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	35632000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	52620000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	409000	USD
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	230000	USD
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	645000	USD
CY2018	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1
CY2017	us-gaap	Depreciation Depreciation	164000	USD
CY2018	us-gaap	Depreciation Depreciation	535000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	166000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	539000	USD
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.63
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.68
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.63
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.68
CY2017	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-11000	USD
CY2018	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	64000	USD
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.167
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.162
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.154
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.006
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.042
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.008
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.005
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.005
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.008
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.039
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	73000	USD
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-48000	USD
CY2017	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2018	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2017	us-gaap	Gross Profit GrossProfit	0	USD
CY2018	us-gaap	Gross Profit GrossProfit	5477000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-30463000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-146247000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-18439000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	39589000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-48902000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-106658000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	0	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2310000	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	6688000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	10150000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2013000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4698000	USD
CY2017	us-gaap	Interest Expense InterestExpense	910000	USD
CY2018	us-gaap	Interest Expense InterestExpense	9229000	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	0	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	8253000	USD
CY2017Q4	us-gaap	Interest Payable Current InterestPayableCurrent	45000	USD
CY2018Q4	us-gaap	Interest Payable Current InterestPayableCurrent	345000	USD
CY2017Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	0	USD
CY2018Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	2819000	USD
CY2017Q4	us-gaap	Inventory Gross InventoryGross	2013000	USD
CY2018Q4	us-gaap	Inventory Gross InventoryGross	7132000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	2013000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	7132000	USD
CY2017Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1385000	USD
CY2018Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	1969000	USD
CY2017Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	628000	USD
CY2018Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2344000	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	303000	USD
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	2453000	USD
CY2018Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P3Y
CY2017Q4	us-gaap	Liabilities Liabilities	86640000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	98378000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	241136000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	216989000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	14777000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	25697000	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	71863000	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	72500000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	236125000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	59579000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2406000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1690000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-35680000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-91817000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-48902000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-106658000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-61967000	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-106658000	USD
CY2017	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
CY2018	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	361000	USD
CY2017	us-gaap	Operating Expenses OperatingExpenses	48530000	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	105717000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-48530000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-100240000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	3128000	USD
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	689000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1630000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	391000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1107000	USD
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	831000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	314000	USD
CY2018Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2183000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	405000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	248000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	435000	USD
CY2017Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1254000	USD
CY2017	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-12000	USD
CY2018	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	54000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-12000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	54000	USD
CY2017Q4	us-gaap	Other Employee Related Liabilities Current And Noncurrent OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent	185000	USD
CY2018Q4	us-gaap	Other Employee Related Liabilities Current And Noncurrent OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent	359000	USD
CY2017Q4	us-gaap	Other Liabilities OtherLiabilities	0	USD
CY2018Q4	us-gaap	Other Liabilities OtherLiabilities	181000	USD
CY2017	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2454000	USD
CY2018	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	USD
CY2017	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	13433000	USD
CY2018	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	6547000	USD
CY2017	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	288000	USD
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	70000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2406000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1690000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	138000000	USD
CY2018	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	63969000	USD
CY2017	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	75000000	USD
CY2018	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2017	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	36712000	USD
CY2018	us-gaap	Proceeds From Issuance Of Redeemable Preferred Stock ProceedsFromIssuanceOfRedeemablePreferredStock	0	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	134000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1488000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2919000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5035000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2564000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3884000	USD
CY2018Q4	us-gaap	Purchase Obligation PurchaseObligation	0	USD
CY2017Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	46000	USD
CY2018Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	242000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16832000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10099000	USD
CY2017Q4	us-gaap	Restricted Cash RestrictedCash	21000	USD
CY2018Q4	us-gaap	Restricted Cash RestrictedCash	21000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-211269000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-317927000	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	0	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7065000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	31698000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	95618000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	5096000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	8543000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	237259000	USD
CY2018	us-gaap	Stock Issued During Period Value Employee Stock Ownership Plan StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan	739000	USD
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	125471000	USD
CY2018	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	59917000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	-154000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1418000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	154496000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	118611000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-151197000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	154496000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	118611000	USD
CY2017Q4	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	2.8879
CY2017	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	1096000	USD
CY2018	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
CY2017	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	11969000	USD
CY2018	us-gaap	Temporary Equity Dividends Adjustment TemporaryEquityDividendsAdjustment	0	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	16988000	USD
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10999121	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39765983	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10999121	shares
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39765983	shares
CY2018	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Concentration of credit risk</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash and accounts receivable.The Company generally invests its cash in deposits with high credit quality financial institutions. Additionally, the Company performs periodic evaluations of the relative credit standing of these financial institutions.</font></div></div>
CY2018	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Organization and Description of Business</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">OptiNose, Inc. (the Company) was incorporated in Delaware in May 2010 (inception) and has facilities in Yardley, Pennsylvania, Ewing, New Jersey, Oslo, Norway and Swindon, England. The Company's predecessor entity, OptiNose AS, was formed under the laws of Norway in September 2000. In 2010, OptiNose AS became a wholly-owned subsidiary of the Company as part of an internal reorganization.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company is a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat (ENT) and allergy specialists. The Company's first commercial product, XHANCE</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">®</sup></font><font style="font-family:Arial;font-size:10pt;"> (fluticasone propionate) nasal spray, 93 mcg, is a therapeutic utilizing its proprietary Optinose Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps and, if approved, chronic rhinosinusitis without nasal polyps (also known as chronic sinusitis). XHANCE was approved by the United States (US) Food and Drug Administration (FDA) in September 2017 for the treatment of nasal polyps in patients 18 years of age or older, and XHANCE was launched commercially in the US in March 2018.</font></div></div>
CY2018	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Use of estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and reported amounts of expenses during the reporting period. Due to the uncertainty of factors surrounding the estimates or judgments used in the preparation of the consolidated financial statements, actual results may materially vary from these estimates. Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary.</font></div></div>

Files In Submission

Name	View Source	Status
0001494650-19-000020-index-headers.html	Edgar Link	pending
0001494650-19-000020-index.html	Edgar Link	pending
0001494650-19-000020.txt	Edgar Link	pending
0001494650-19-000020-xbrl.zip	Edgar Link	pending
auditorconsent10-kex231.htm	Edgar Link	pending
capture.jpg	Edgar Link	pending
edsworksa01.jpg	Edgar Link	pending
exhibit1020optnvtmopn_image1.gif	Edgar Link	pending
exhibit1020_optn-vtmopnass.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
formindemnificationagreeme.htm	Edgar Link	pending
gammamri2a01.jpg	Edgar Link	pending
gammamria01.jpg	Edgar Link	pending
listofsubsidiariesex211.htm	Edgar Link	pending
nasalpassagea01.jpg	Edgar Link	pending
navigateia01.jpg	Edgar Link	pending
navigateiia01.jpg	Edgar Link	pending
optinoselogorgba25.jpg	Edgar Link	pending
optn-20181231.xml	Edgar Link	completed
optn-20181231.xsd	Edgar Link	pending
optn-20181231_cal.xml	Edgar Link	unprocessable
optn-20181231_def.xml	Edgar Link	unprocessable
optn-20181231_lab.xml	Edgar Link	unprocessable
optn-20181231_pre.xml	Edgar Link	unprocessable
optn12-31x201810xk.htm	Edgar Link	pending
optn12-31x201810xkex311.htm	Edgar Link	pending
optn12-31x201810xkex312.htm	Edgar Link	pending
optn12-31x201810xkex321.htm	Edgar Link	pending
optn12-31x201810xkex322.htm	Edgar Link	pending
pipeline2019a04.jpg	Edgar Link	pending
powderedsa02.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPTN
OptiNose, Inc. Stock $optn

2019 Q1 Form 10-K Financial Statement

#000149465019000020 Filed on March 06, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPTN OptiNose, Inc. Stock $optn

2019 Q1 Form 10-K Financial Statement

#000149465019000020 Filed on March 06, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPTN
OptiNose, Inc. Stock $optn